Topical bioavailability of diclofenac from locally-acting, dermatological formulations

被引:43
|
作者
Cordery, S. F. [1 ]
Pensado, A. [1 ]
Chiu, W. S. [1 ]
Shehab, M. Z. [1 ]
Bunge, A. L. [2 ]
Delgado-Charro, M. B. [1 ]
Guy, R. H. [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England
[2] Colorado Sch Mines, Chem & Biol Engn, Golden, CO 80401 USA
关键词
Diclofenac; Skin; Topical bioavailability; Topical bioequivalence; Dermato-pharmacokinetics; HUMAN STRATUM-CORNEUM; IN-VIVO; PERCUTANEOUS-ABSORPTION; DRUG PRODUCTS; BIOEQUIVALENCE; SKIN; VITRO;
D O I
10.1016/j.ijpharm.2017.06.063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Assessment of the bioavailability of topically applied drugs designed to act within or beneath the skin is a challenging objective. A number of different, but potentially complementary, techniques are under evaluation. The objective of this work was to evaluate in vitro skin penetration and stratum corneum tape-stripping in vivo as tools with which to measure topical diclofenac bioavailability from three approved and commercialized products (two gels and one solution). Drug uptake into, and its subsequent clearance from, the stratum corneum of human volunteers was used to estimate the input rate of diclofenac into the viable skin layers. This flux was compared to that measured across excised porcine skin in conventional diffusion cells. Both techniques clearly demonstrated (a) the superiority in terms of drug delivery from the solution, and (b) that the two gels performed similarly. There was qualitative and, importantly, quantitative agreement between the in vitro and in vivo measurements of drug flux into and beyond the viable skin. Evidence is therefore presented to support an in vivo - n vitro correlation between methods to assess topical drug bioavailability. The potential value of the stratum corneum tapestripping technique to quantify drug delivery into (epi) dermal and subcutaneous tissue beneath the barrier is demonstrated. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 50 条
  • [21] Bioavailability of two long-acting formulations of methylphenidate
    Markowitz, JS
    Straughn, A
    Patrick, KS
    DeVane, CL
    Pestreich, L
    Lee, J
    Wang, YF
    Muniz, R
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (04) : 417 - 418
  • [22] Enhancement of bioavailability by lowering of fat content in topical formulations
    Wiren, K.
    Frithiof, H.
    Sjoqvist, C.
    Loden, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (03) : 552 - 556
  • [23] FACTORS TO BE CONSIDERED IN THE EVALUATION OF BIOAVAILABILITY AND BIOEQUIVALENCE OF TOPICAL FORMULATIONS
    BORSADIA, S
    GHANEM, AH
    SETA, Y
    HIGUCHI, WI
    FLYNN, GL
    BEHL, CR
    SHAH, VP
    SKIN PHARMACOLOGY, 1992, 5 (03): : 129 - 145
  • [24] Formulation and Evaluation of the In Vitro Performance of Topical Dermatological Products Containing Diclofenac Sodium
    Manian, Mahima
    Jain, Piyush
    Vora, Deepal
    Banga, Ajay K.
    PHARMACEUTICS, 2022, 14 (09)
  • [25] COMPARATIVE BIOAVAILABILITY OF 2 TABLET FORMULATIONS OF DICLOFENAC SODIUM IN NORMAL SUBJECTS
    HASAN, MM
    NAJIB, NM
    RAWASHDEH, NM
    SALLAM, EN
    SHUBAIR, MS
    ALAWNEH, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1991, 29 (05) : 178 - 183
  • [26] Influence of tropical climatic conditions on the bioavailability of two diclofenac sodium formulations
    Van den Abeele, WM
    Risha, PG
    Vergote, G
    Vervaet, C
    Remon, JP
    Van Bortel, LM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 465 - 465
  • [27] THE EVOLUTION OF MAMMARY CANCER INDUCED IN VIRGIN FEMALE IF MICE WITH MINIMAL DOSES OF LOCALLY-ACTING METHYLCHOLANTHRENE
    BONSER, GM
    JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1954, 68 (02): : 531 - &
  • [28] Increased absorption rate of diclofenac from fast acting formulations containing its potassium salt
    Reiner, V
    Reiner, A
    Reiner, G
    Conti, M
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51 (11): : 885 - 890
  • [29] Bioavailability and Tolerability of Topical and Oral Diclofenac Sodium Administration in Healthy Ponies
    Azevedo, Marcos S.
    De La Corte, Flavio D.
    Brass, Karin E.
    Dalmora, Sergio L.
    Machado, Francine T.
    Pompermayer, Endrigo
    Dau, Stefano L.
    Santa'Ana, Laureana A.
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2013, 33 (01) : 22 - 26
  • [30] Nanosuspensions and Microneedles Roller as a Combined Approach to Enhance Diclofenac Topical Bioavailability
    Pireddu, Rosa
    Schlich, Michele
    Marceddu, Salvatore
    Valenti, Donatella
    Pini, Elena
    Fadda, Anna Maria
    Lai, Francesco
    Sinico, Chiara
    PHARMACEUTICS, 2020, 12 (12) : 1 - 14